دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Three-dimensional Model Reconstruction: The Need for Standardization to Drive Tailored Surgery
EnricoCheccucciabcPietroPiazzadeSalvatoreMicalifAhmedGhazigAlexandreMottrieehFrancescoPorpigliab†StefanoPuliatticeh†the Uro-technology, SoMe Working Group of the Young Academic Urologists of the European Association of Urology
Sex and Gender Differences in Cancers of the Genitourinary Tract: The Need to Consider Immune Divergence
MadhuriKotiabcD.Robert Siemensabc
2021 Updated European Association of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell Carcinoma
JensBedkeabLaurenceAlbigescUmbertoCapitaniodeRachel H.GilesfMilanHoragThomas B.LamhiBörjeLjungbergjLorenzoMarconikTobiasKlattelAlessandroVolpemYasminAbu-GhanemnSaeedDabestanioSergioFernández-PellopFabianHofmannqTeeleKuuskrsRanaTahbazlThomasPowlestAxelBexuvw
A Molecular Inquiry into the Role of Antibody-Drug Conjugates in Bacillus Calmette-Guérin-exposed Non–muscle-invasive Bladder Cancer
WoonyoungChoiab1KaraLombardoab1SunilPatelaGabrielEpsteinabMingxiaoFengabAndrewGabrielsonaNoah M.HahnabcJeanHoffman-CensitsbcDavidMcConkeyabcTrinity J.BivalacquaabcAndresMatosoabcdMaxKatesabc
Not “If�, but “When� and “How�: Testing Antibody-Drug Conjugates in Patients with Non–muscle-invasive Bladder Cancer
Moritz J.ReikeRoyAdarPeter C.Black
The Significance of PARP1 as a biomarker for Predicting the Response to PD-L1 Blockade in Patients with PBRM1-mutated Clear Cell Renal Cell Carcinoma
MasayukiHagiwaraabAtsushiFushimiaKazuhiroMatsumotobMototsuguOyab
Combination Strategies for Immune Checkpoint Inhibitors in PBRM1-mutant Renal Cell Carcinoma: To PARP or Not To PARP?
Elena V.DemidovaabPoojaGhataliacSanjeevaniAroraad
Urinary Tract Infections in Children with Vesicoureteral Reflux Are Accompanied by Alterations in Urinary Microbiota and Metabolome Profiles
DijanaVitkoad†Joseph W.McQuaidb†Ali HashemiGheinaniacdKoheiHasegawaeShannonDiMartinoaKylie H.DavisaCandace Y.ChungaJoseph F.PetrosinofRosalyn M.AdamacdJonathan M.Mansbachg‡Richard S.Leead‡
Vesicoureteral Reflux, Renal Scars, and Urinary Tract Infections in Children: A New Way to Think About an Old Problem
Armando J.Lorenzo
Prehabilitation Exercise Before Urologic Cancer Surgery: A Systematic and Interdisciplinary Review
Logan G.BriggsaChananReitblataPaul A.BainbSaraParkecNy-YingLamdJonathanWrighteJames W.F.CattofRobert J.CopelandgSarah P.Psutkae
Intracorporeal Versus Extracorporeal Robot-assisted Kidney Autotransplantation: Experience of the ERUS RAKT Working Group
AlbertoBredaa†PietroDianaab†AngeloTerritoaAndreaGallioliaAlbertoPianaaJosep MariaGayaaPavelGavrilovaLiesbethDesendercBenjaminVan ParysdCharlesVan PraetdEdwardLambertdZine-EddineKheneeVan ThiDangfNicolasDoumercf‡KarelDecaesteckerd‡
Durable Treatment of Refractory Vesicourethral Anastomotic Stenosis via Robotic-assisted Reconstruction: A Trauma and Urologic Reconstructive Network of Surgeons Study
Nabeel A.ShakiraNejd F.AlsikafibJulia F.BuesserbGregoryAmendcBenjamin N.BreyercJill C.BuckleydBradley A.EricksoneJoshua A.BroghammerfWilliam P.ParkerfLee C.Zhaoa
Deep Prostate-specific Antigen Response following Addition of Apalutamide to Ongoing Androgen Deprivation Therapy and Long-term Clinical Benefit in SPARTAN
FredSaada1Eric J.Smallb1Felix Y.FengbJulie N.GraffcdDavidOlmosefBoris A.HadaschikghStéphaneOudardiAnilLondhejAmitabhaBhaumikjAngelaLopez-GitlitzkShibuThomaslSuneel D.MundlemSimonChowdhurynMatthew R.Smitho
Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk Groups
ElioMazzonea†GiorgioGandagliaa†GuillamePloussardbcGiancarloMarradMassimoValerioeRiccardoCampifgAndreaMarifgAndreaMinervinifgSergioSernifgMarcoMoschinihAlessandroMarquisdJean BaptisteBeauvaliRoderickvan den BerghjRazvan-GeorgeRahotabcTimoSoeterikjkMathieuRoumiguièiLucaAfferihJunlongZhuangl…AlbertoBrigantia
Rare and Complex Urology: Clinical Overview of ERN eUROGEN
LoesOomena†ErikLeijtea†Darren E.ShilhanbMichelleBattyeb
Re: Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021
Florian M.E.WagenlehnerFlorianDittmar
Re: Comparative Safety and Efficacy of Treatments for Overactive Bladder Among Older Adults: A Network Meta-analysis
JoséMedina-Polo
Re: Impact of the Implementation of the EAU Guidelines Recommendation on Reporting and Grading of Complications in Patients Undergoing Robot-assisted Radical Cystectomy: A Systematic Review
Niranjan J.SathianathenaNathanLawrentschukaGeorge N.ThalmannbMarc A.Furrerabc
Re: Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study
MathieuSpaasabNoraSundahlabPietOstbc
Re: A Prospective Prostate Cancer Screening Programme for Men with Pathogenic Variants in Mismatch Repair Genes (IMPACT): Initial Results from an International Prospective Study
VittorioFasuloabMonicaZuradelliacMassimoLazzeriab
Re: NCCN Prostate Cancer Guidelines Version 1.2022 – September 10, 2021
JeremyGrummetaScottEggenerb
Hyperpolarized 1-[13C]-Pyruvate Magnetic Resonance Imaging Detects an Early Metabolic Response to Immune Checkpoint Inhibitor Therapy in Prostate Cancer
Ivande KouchkovskyaHsin-YuChenbMichael A.OhligerbZhen J.WangbRobert A.BokbJeremy W.GordonbPeder E.Z.LarsonbMaryFrostbKimberlyOkamotobMatthew R.CooperbergcJohnKurhanewiczbDaniel B.VigneronbRahulAggarwala
Re: Anna Lantz, David Bock, Olof Akre, et al. Functional and Oncological Outcomes After Open Versus Robot-assisted Laparoscopic Radical Prostatectomy for Localised Prostate Cancer: 8-Year Follow-up. Eur Urol 2021;80:650–60
Wei ZhengSoaZitingWangbHo YeeTiongb
Reply to Wei Zhang So, Ziting Wang, and Ho Yee Tiong’s Letter to the Editor re: Anna Lantz, David Bock, Olof Akre, et al. Functional and Oncological Outcomes After Open Versus Robot-assisted Laparoscopic Radical Prostatectomy for Localised Prostate Cancer: 8-Year Follow-up. Eur Urol 2021;80:650–60
AnnaLantzabDavidBockcOlofAkreaEvaAngenetecdAndersBjartellefStefanCarlssonaKatarinaKoss ModigghMartinNybergefKarinStinesen KollberggiGunnarSteineckjJohanStranneghPeterWiklundakEvaHaglindcd
Re: Riccardo Campi, Riccardo Bertolo, Andrea Minervini, European Association of Urology Young Academic Urologists Renal Cancer Working Group. Re: Partial Versus Radical Nephrectomy in Clinical T2 Renal Masses. Klett DE, Tsivian M, Packiam VT, et al. Int J Urol. 2021;28:1149–54. Eur Urol. 2021;80:760–2: Partial Nephrectomy for T2 Kidney Cancer Might Violate the Declaration of Helsinki
TakeshiTakahashi*
Reply to Takeshi Takahashi’s Letter to the Editor re: Riccardo Campi, Riccardo Bertolo, Andrea Minervini, European Association of Urology Young Academic Urologists Renal Cancer Working Group. Re: Partial Versus Radical Nephrectomy in Clinical T2 Renal Masses. Klett DE, Tsivian M, Packiam VT, et al. Int J Urol. 2021;28:1149–54. Eur Urol 2021;80;760–2. Partial Nephrectomy for T2 Kidney Cancer Might Violate the Declaration of Helsinki: Re-envisioning the Value of Clinical Research to Foster the Progress of Evidence-based Urology: The Case of Partial Nephrectomy for cT2 Renal Masses
RiccardoCampiabRiccardoBertolocAndreaMinervinibdthe European Association of Urology Young Academic Urologists Renal Cancer Working Group
Re: Jana S. Hopstaken, Joyce G.R. Bomers, Michiel J.P. Sedelaar, Massimo Valerio, Jurgen J. Fütterer, Maroeska M. Rovers. An Updated Systematic Review on Focal Therapy in Localized Prostate Cancer: What Has Changed over the Past 5 Years? Eur Urol. 2021;81:5–33
Anthony T.NguyenMitchellKamrava
Re: Anthony Emmanuel, Abi Kanthabalan, Cameron Alexander, et al. Expedited Radical Orchidectomy for Testicular Cancer: Compromising Fertility Outcomes Without Oncological Benefit? Eur Urol. 2020;80:766–7
Akshat M.PatelaJeffrey M.HowardaAdityaBagrodiab
Re: Jeremy Yuen-Chun Teoh, Daniele Castellani, Claudia Mercader, et al. A Quantitative Analysis Investigating the Prevalence of “Manels� in Major Urology Meetings. Euro Urol 2021;80:442–9
James T.RutkaaNeilFleshnerbAvery B.Nathensc
Corrigendum to “Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT)� [Eur Urol 77 (2020) 713–24]
Timothy J.WiltabTien N.VocLisaLangsetmocPhilippDahmdeThomasWheelerfWilliam J.AronsonghMatthew R.CooperbergijBrent C.TaylorabMichael K.Brawerkl
Corrigendum to “Identification of Differential Tumor Subtypes of T1 Bladder Cancer� [Eur. Urol. 78 (2020) 533–537]
A. GordonRobertsonaClarice S.GroeneveldbcBrianJordandXiaoqiLineKimberly A.McLaughlinfArighnoDasfLeigh AnnFallfDamianoFantinifTimothy J.TaxterhLauren S.MogiliSia ViborgLindskrogjLarsDyrskjøtjDavid J.McConkeykRobert S.SvateklmAuréliende ReynièsbMauro A.A.CastronJoshua J.Meeksfg
